Qiagen NV Profit Margin

The latest profit margin for QGEN is 19.16% as of March 2026. That compares with 4.68% in the prior-year period — up 309.7% year over year. That is above the Healthcare sector average of 15.29%. Investors often review this figure alongside Qiagen NV's historical trend and sector peers before judging valuation or financial health.

Over the past year, QGEN's profit margin moved from 4.68% to 19.16% — a 309.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Qiagen NV's valuation or profitability profile.

Against Healthcare companies, QGEN currently prints 19.16% for profit margin, while the sector average sits near 15.29%. That is roughly 25.3% above the sector mean. Large gaps often invite a closer look at Qiagen NV's growth, margins, and balance sheet.

Profit Margin shows how effectively Qiagen NV converts resources into returns. At 19.16%, QGEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.68% in the prior-year period — up 309.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting QGEN's profit margin (19.16%), review year-over-year change from 4.68%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.